Antimicrobial Susceptibility Testing Market Outlook Report: Latest Trends and Growth Opportunities by Region

Published On: Jan, 2025
|
Pages: 161

"The Global Antimicrobial Susceptibility Testing Market Size was valued at USD 4.0 billion in 2024 and is projected to reach USD 4.2 billion in 2025. Worldwide sales of Antimicrobial Susceptibility Testing are expected to grow at a significant CAGR of 5.5%, reaching USD 6.9 billion by the end of the forecast period in 2034."

The antimicrobial susceptibility testing (AST) market plays a vital role in modern healthcare systems, providing critical diagnostic tools to determine the effectiveness of antibiotics and guide targeted treatment decisions. This market has grown significantly in recent years due to the alarming rise of antimicrobial resistance (AMR) and the urgent need for robust surveillance and diagnostics to curb the misuse of antibiotics. AST methods, including manual, automated, and molecular-based systems, help healthcare professionals select the most appropriate antimicrobial therapy, reduce treatment failures, and limit the spread of resistant pathogens. Key end users include hospitals, diagnostic laboratories, research institutions, and pharmaceutical companies engaged in developing new antibiotics. Stringent regulatory requirements and increased awareness of hospital-acquired infections further drive market demand. Governments and global health bodies continue to emphasize better diagnostic stewardship, fueling investment in advanced and rapid AST solutions. The market benefits from a growing pipeline of novel AST devices that deliver faster, accurate results, minimizing the time needed to prescribe effective treatments.

Regionally, North America and Europe dominate the AST market, supported by strong healthcare infrastructure, high testing volumes, and proactive antimicrobial resistance management policies. However, Asia-Pacific is emerging as a high-growth region, driven by rising infection rates, expanding laboratory capacity, and increasing public and private healthcare investments. Automation and digitization trends are transforming laboratory workflows, enabling laboratories to handle larger testing volumes with higher accuracy and efficiency. Companies in the AST space are focusing on developing rapid, cost-effective, and point-of-care testing solutions to address the growing demand for quicker diagnostics in critical care settings. However, challenges such as high costs of advanced instruments, lack of skilled personnel in emerging markets, and regulatory hurdles can hamper wider adoption. Collaborations between industry players, research institutes, and government health agencies are crucial to accelerating new product approvals and expanding awareness about AMR. Overall, the antimicrobial susceptibility testing market is positioned for steady growth as it remains central to combating drug resistance and safeguarding global public health.

In the antimicrobial susceptibility testing market by product, consumables are the largest segment. This is because consumables such as media, reagents, and testing panels are required regularly for each test performed in laboratories and hospitals. Their recurring use generates consistent demand, making consumables the dominant revenue contributor for companies operating in the market.

By application, clinical diagnostics is the largest segment in the antimicrobial susceptibility testing market. This dominance is driven by the high burden of infectious diseases and hospital-acquired infections, requiring routine testing to guide appropriate antimicrobial therapy. Hospitals and diagnostic laboratories conduct a large volume of these tests, ensuring strong and stable demand for clinical diagnostic applications.

Global Antimicrobial Susceptibility Testing (AST) Market Analysis 2025-2032: Industry Size, Share, Growth Trends, Competition and Forecast Report

Key Insights

  • Increasing prevalence of antimicrobial resistance globally is the primary driver for the AST market, as clinicians and hospitals rely on accurate testing to choose effective treatments. Rising incidences of multi-drug resistant infections are pushing healthcare providers to adopt advanced diagnostic tools for timely intervention and infection control.
  • Automated antimicrobial susceptibility testing systems are witnessing higher adoption due to their ability to deliver standardized, high-throughput, and rapid results. Automation minimizes human error, reduces turnaround time, and enhances workflow efficiency in busy hospital and reference laboratories.
  • The market is also benefiting from technological advancements such as rapid molecular diagnostic platforms and next-generation sequencing (NGS) tools. These solutions enable faster pathogen identification and resistance profiling, supporting precision medicine initiatives in infectious disease management.
  • Hospitals and diagnostic laboratories are the largest end-users, driven by the high burden of hospital-acquired infections and the need for routine susceptibility testing. Increasing awareness of infection control practices and regulatory mandates for AMR surveillance are further boosting demand in these segments.
  • Asia-Pacific is emerging as a high-potential market for AST, supported by growing investments in healthcare infrastructure, rising awareness of AMR, and government-led surveillance programs. Countries like India and China are scaling up laboratory capacity to handle rising infection rates and improve diagnostic accuracy.
  • Point-of-care antimicrobial susceptibility testing is gaining traction, especially for use in emergency departments and outpatient clinics. The ability to provide rapid results at the patient’s bedside is transforming clinical decision-making and reducing unnecessary antibiotic prescriptions.
  • Leading companies are investing in research and development to launch innovative testing panels, consumables, and integrated diagnostic platforms. Partnerships with research institutions and public health organizations are key strategies to enhance technology validation and market penetration.
  • Stringent regulatory frameworks and quality standards ensure reliability of AST results but can pose challenges for new product approvals. Companies must navigate diverse country-specific regulations and obtain multiple certifications to market their products globally.
  • Shortage of trained laboratory personnel, particularly in low- and middle-income countries, is a major constraint. This creates a need for user-friendly, automated systems that can be operated with minimal specialized training while maintaining accuracy and reliability.
  • Collaborative efforts among healthcare providers, diagnostic manufacturers, and policymakers are vital to curb antimicrobial resistance. Expanding educational campaigns and funding support for diagnostic stewardship programs play an important role in driving adoption of AST technologies worldwide.

Reort Scope

Parameter Detail
Base Year 2024
Estimated Year 2025
Forecast Period 2026-2034
Market Size-Units USD billion
Market Splits Covered By Product, By Method, By Application, By End User
Countries Covered North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Rest of Europe)
Asia-Pacific (China, India, Japan, Australia, Rest of APAC)
The Middle East and Africa (Middle East, Africa)
South and Central America (Brazil, Argentina, Rest of SCA)
Analysis Covered Latest Trends, Driving Factors, Challenges, Supply-Chain Analysis, Competitive Landscape, Company Strategies
Customization 10 % free customization (up to 10 analyst hours) to modify segments, geographies, and companies analyzed
Post-Sale Support 4 analyst hours, available up to 4 weeks
Delivery Format The Latest Updated PDF and Excel Datafile

Market Segmentation

By Product:

  • Manual Testing Products
  • Automated Testing Systems
  • Consumables

By Method:

 

  • Disk Diffusion
  • Dilution
  • E-test

By Application:

  • Clinical Diagnostics
  • Drug Discovery and Development
  • Others

By End User:

  • Hospitals and Diagnostic Centers
  • Pharmaceutical and Biotechnology Companies
  • Research and Academic Institutes

By Regian

  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Spain, Italy, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Rest of APAC)
  • The Middle East and Africa (Middle East, Africa)
  • South and Central America (Brazil, Argentina, Rest of SCA)

What You Receive

• Global Antimicrobial Susceptibility Testing market size and growth projections (CAGR), 2024- 2034
• Impact of recent changes in geopolitical, economic, and trade policies on the demand and supply chain of Antimicrobial Susceptibility Testing.
• Antimicrobial Susceptibility Testing market size, share, and outlook across 5 regions and 27 countries, 2025- 2034.
• Antimicrobial Susceptibility Testing market size, CAGR, and Market Share of key products, applications, and end-user verticals, 2025- 2034.
• Short and long-term Antimicrobial Susceptibility Testing market trends, drivers, restraints, and opportunities.
• Porter’s Five Forces analysis, Technological developments in the Antimicrobial Susceptibility Testing market, Antimicrobial Susceptibility Testing supply chain analysis.
• Antimicrobial Susceptibility Testing trade analysis, Antimicrobial Susceptibility Testing market price analysis, Antimicrobial Susceptibility Testing Value Chain Analysis.
• Profiles of 5 leading companies in the industry- overview, key strategies, financials, and products.
• Latest Antimicrobial Susceptibility Testing market news and developments.
The Antimicrobial Susceptibility Testing Market international scenario is well established in the report with separate chapters on North America Antimicrobial Susceptibility Testing Market, Europe Antimicrobial Susceptibility Testing Market, Asia-Pacific Antimicrobial Susceptibility Testing Market, Middle East and Africa Antimicrobial Susceptibility Testing Market, and South and Central America Antimicrobial Susceptibility Testing Markets. These sections further fragment the regional Antimicrobial Susceptibility Testing market by type, application, end-user, and country.

Who can benefit from this research

The research would help top management/strategy formulators/business/product development/sales managers and investors in this market in the following ways
1. The report provides 2024 Antimicrobial Susceptibility Testing market sales data at the global, regional, and key country levels with a detailed outlook to 2034, allowing companies to calculate their market share and analyze prospects, uncover new markets, and plan market entry strategy.
2. The research includes the Antimicrobial Susceptibility Testing market split into different types and applications. This segmentation helps managers plan their products and budgets based on the future growth rates of each segment
3. The Antimicrobial Susceptibility Testing market study helps stakeholders understand the breadth and stance of the market giving them information on key drivers, restraints, challenges, and growth opportunities of the market and mitigating risks
4. This report would help top management understand competition better with a detailed SWOT analysis and key strategies of their competitors, and plan their position in the business
5. The study assists investors in analyzing Antimicrobial Susceptibility Testing business prospects by region, key countries, and top companies' information to channel their investments.

Available Customizations

The standard syndicate report is designed to serve the common interests of Antimicrobial Susceptibility Testing Market players across the value chain and include selective data and analysis from entire research findings as per the scope and price of the publication.
However, to precisely match the specific research requirements of individual clients, we offer several customization options to include the data and analysis of interest in the final deliverable.

Some of the customization requests are as mentioned below :
Segmentation of choice – Our clients can seek customization to modify/add a market division for types/applications/end-uses/processes of their choice.
Antimicrobial Susceptibility Testing Pricing and Margins Across the Supply Chain, Antimicrobial Susceptibility Testing Price Analysis / International Trade Data / Import-Export Analysis
Supply Chain Analysis, Supply–Demand Gap Analysis, PESTLE Analysis, Macro-Economic Analysis, and other Antimicrobial Susceptibility Testing market analytics
Processing and manufacturing requirements, Patent Analysis, Technology Trends, and Product Innovations
Further, the client can seek customization to break down geographies as per their requirements for specific countries/country groups such as South East Asia, Central Asia, Emerging and Developing Asia, Western Europe, Eastern Europe, Benelux, Emerging and Developing Europe, Nordic countries, North Africa, Sub-Saharan Africa, Caribbean, The Middle East and North Africa (MENA), Gulf Cooperation Council (GCC) or any other.
Capital Requirements, Income Projections, Profit Forecasts, and other parameters to prepare a detailed project report to present to Banks/Investment Agencies.
Customization of up to 10% of the content can be done without any additional charges.
Note: Latest developments will be updated in the report and delivered within 2 to 3 working days.

   

  

Get Free Sample

At OG Analysis, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.

Start Now! Please fill the form below for your free sample.

Why Request a Free Sample?

Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.

Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.

Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.

Embark on your journey towards strategic decision-making by requesting a free sample from OG Analysis. Experience the caliber of insights that can transform the way you approach your business challenges.

You can purchase individual sections of this report. Explore pricing options for specific sections.

FAQ's

The Antimicrobial Susceptibility Testing Market is estimated to reach USD 6.1 billion by 2032.

The Global Antimicrobial Susceptibility Testing Market is expected to grow at a Compound Annual Growth Rate (CAGR) of 5.5% during the forecast period from 2025 to 2032.

The Global Antimicrobial Susceptibility Testing Market is estimated to generate USD 4 billion in revenue in 2024.

License

Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM

Need something within your budget? NO WORRIES! WE GOT YOU COVERED!

Related Products

Medical Gas Pipeline System Market Analysis and Outlook Report: Industry Size, Share, Growth Trends, and Forecast (2025-2034)

The Medical Gas Pipeline System Market serves as a foundational element in modern healthcare infrastructure, delivering vital gases such as oxygen, nitrous oxide, medical air, and vacuum to various departments in hospitals and healthcare facilities. These systems ensure uninterrupted gas flow to operating rooms, intensive care units, emergency wards, and patient bedsides, playing a critical role in patient safety and treatment outcomes. Built on a network of pipelines, control panels, zone valves, and alarm systems, medical gas pipeline systems must comply with rigorous international standards to guarantee purity, pressure consistency, and fault tolerance. The demand for these systems is rising sharply with the global expansion of hospitals, particularly in developing regions where healthcare access is rapidly improving. Simultaneously, retrofitting and modernization projects in established hospitals are driving upgrades to digital and automated pipeline systems. In 2024, market developments have been largely shaped by growing investments in healthcare infrastructure and increased awareness of medical gas delivery safety—especially post-pandemic. Manufacturers are focusing on offering modular and scalable pipeline solutions tailored for both large urban hospitals and smaller regional clinics. Integration with centralized monitoring systems is becoming standard, allowing real-time tracking of gas flow, leakage detection, and automated alerts. There is a notable shift toward environmentally friendly systems, with some providers incorporating gas recycling or low-leakage technology to reduce waste. Governments and private hospital chains are increasingly prioritizing projects that not only meet safety codes but also improve energy efficiency and maintenance efficiency. As healthcare becomes more digitized, medical gas pipeline systems are evolving into smart, connected infrastructure—crucial not only for operational efficiency but also for clinical excellence and emergency preparedness. Key Takeaways – Medical Gas Pipeline System Market Medical gas pipeline systems are essential for the delivery of life-supporting gases and vacuum in hospitals, making them critical to patient care and clinical efficiency. Demand is increasing globally due to expanding healthcare infrastructure, particularly in emerging economies where new hospitals and clinics are being rapidly constructed. Digital integration is trending, with hospitals seeking centralized control systems for real-time monitoring, alarm management, and leak detection. Modular and customizable pipeline systems are gaining traction, allowing tailored installations that fit unique architectural and operational requirements. Energy-efficient designs and low-leakage materials are being prioritized to support sustainability goals and reduce operational gas losses. One major driver is the surge in surgical and ICU procedures requiring reliable oxygen and vacuum supply, especially post-COVID-19. Governments are mandating stricter compliance to safety standards such as NFPA 99, ISO 7396, and HTM 02-01, pushing healthcare providers to upgrade older systems. Integration with hospital building management systems (BMS) is improving operational transparency and response times in emergency scenarios. Upfront installation costs and the need for skilled labor remain key challenges for small- and medium-sized healthcare facilities. Another challenge is the logistical complexity of retrofitting existing hospitals with modern systems without disrupting ongoing medical services. North America and Europe dominate the market in terms of compliance-driven upgrades, while Asia-Pacific leads in new installations due to hospital construction booms. Manufacturers are increasingly offering turnkey services including system design, installation, and maintenance to improve customer retention and long-term engagement. Technological collaborations between medical device companies and engineering firms are enabling smarter, data-driven gas pipeline infrastructure. Hospital chains are favoring multi-site standardized pipeline systems to streamline operations and maintenance across facilities. Market players are innovating with touch-screen control panels, wireless alert systems, and predictive maintenance tools to elevate system usability and safety. Parameter Detail Base Year 2024 Estimated Year 2025 Forecast Period 2026-2032 Market Size-Units USD billion Market Splits Covered By Product Type, By Application, By End User, By Technology, By Distribution Channel Countries Covered North America (USA, Canada, Mexico) Europe (Germany, UK, France, Spain, Italy, Rest of Europe) Asia-Pacific (China, India, Japan, Australia, Rest of APAC) The Middle East and Africa (Middle East, Africa) South and Central America (Brazil, Argentina, Rest of SCA) Analysis Covered Latest Trends, Driving Factors, Challenges, Trade Analysis, Price Analysis, Supply-Chain Analysis, Competitive Landscape, Company Strategies Customization 10% free customization (up to 10 analyst hours) to modify segments, geographies, and companies analyzed Post-Sale Support 4 analyst hours, available up to 4 weeks Delivery Format The Latest Updated PDF and Excel Datafile

Published:May-2025

Volumetric Infusion Pumps Market Analysis and Outlook Report: Industry Size, Share, Growth Trends, and Forecast (2025-2034)

The Volumetric Infusion Pumps Market is experiencing significant growth, driven by the increasing demand for precise and continuous fluid delivery systems across hospitals, clinics, and homecare settings. These pumps are essential for delivering medications, nutrients, and fluids in controlled volumes, making them critical in managing chronic diseases, post-operative recovery, and emergency care. The rise in global healthcare expenditure, an aging population, and the increasing prevalence of conditions such as cancer, diabetes, and cardiovascular diseases are major contributors to market expansion. Volumetric infusion pumps are particularly valued in intensive care units and oncology centers for their accuracy and ability to manage complex drug regimens. Technological advancements such as wireless connectivity, integration with electronic health records (EHR), and automated drug libraries are making these devices safer and more efficient, which is further stimulating market adoption in developed as well as emerging regions. The market also benefits from the growing shift toward ambulatory and home-based care, with patients increasingly managing long-term health conditions outside of traditional hospital environments. Portable and battery-powered volumetric infusion pumps are enabling this transition, offering convenience and reducing the cost burden on healthcare systems. However, challenges such as device recalls due to software glitches, product safety concerns, and stringent regulatory approval processes are creating headwinds for market players. Despite these challenges, ongoing R&D and product innovation are helping companies to develop more reliable, user-friendly, and smart infusion systems. North America holds a major share of the global market due to its advanced healthcare infrastructure, while the Asia-Pacific region is expected to register rapid growth due to healthcare modernization, increasing medical awareness, and rising demand for advanced therapeutic devices. As personalized medicine and digital health continue to evolve, volumetric infusion pumps are likely to play a central role in delivering safe, efficient, and tailored treatment solutions. Key Takeaways The demand for volumetric infusion pumps is increasing due to the growing global burden of chronic diseases, especially diabetes and cancer. These conditions require long-term and precise drug administration, making infusion pumps a critical component in patient care, particularly in hospital and oncology settings. Technological advancements such as smart infusion systems, wireless connectivity, and drug library integration are enhancing the safety and efficiency of volumetric infusion pumps. These innovations help reduce human error, streamline workflows for clinicians, and support better compliance with clinical guidelines. Home healthcare is emerging as a significant end-use segment for volumetric infusion pumps, driven by the aging population and preference for at-home treatments. Portable and battery-operated models are increasingly adopted for palliative care, pain management, and chronic disease therapies. North America remains the dominant regional market due to high healthcare spending, established hospital infrastructure, and early adoption of advanced technologies. The United States contributes a significant portion of the demand, especially for oncology and ICU applications. The Asia-Pacific region is experiencing rapid growth in the volumetric infusion pumps market, fueled by healthcare infrastructure improvements, government support, and rising demand for affordable medical equipment. Countries like China, India, and South Korea are expanding their usage in tertiary and primary care. Regulatory scrutiny and product recalls related to software malfunctions and device safety have challenged manufacturers. Compliance with FDA and CE requirements is essential for maintaining market presence and customer trust, particularly in the hospital procurement process. Pediatric and neonatal care units are increasingly adopting volumetric infusion pumps for accurate dosing. Precision in fluid delivery is crucial for infants and children, where slight variations can lead to adverse outcomes, emphasizing the need for reliable devices. Competitive pricing and the entry of local manufacturers in emerging markets are intensifying price competition. Companies are focusing on developing cost-effective yet high-performance pumps to cater to budget-sensitive healthcare facilities. The integration of volumetric pumps with electronic health records (EHRs) and hospital information systems is streamlining documentation and enhancing real-time monitoring. This digital integration helps ensure transparency in drug administration and improves auditability. Infusion pump rentals and leasing models are gaining popularity among healthcare providers, especially smaller clinics and homecare service providers. These models offer cost flexibility and allow facilities to access the latest technologies without large upfront capital investments. Report Scope Parameter Detail Base Year 2024 Estimated Year 2025 Forecast Period 2026-2032 Market Size-Units USD billion Market Splits Covered By Product Type, By Application, By End User, By Technology, By Distribution Channel Countries Covered North America (USA, Canada, Mexico) Europe (Germany, UK, France, Spain, Italy, Rest of Europe) Asia-Pacific (China, India, Japan, Australia, Rest of APAC) The Middle East and Africa (Middle East, Africa) South and Central America (Brazil, Argentina, Rest of SCA) Analysis Covered Latest Trends, Driving Factors, Challenges, Trade Analysis, Price Analysis, Supply-Chain Analysis, Competitive Landscape, Company Strategies Customization 10% free customization (up to 10 analyst hours) to modify segments, geographies, and companies analyzed Post-Sale Support 4 analyst hours, available up to 4 weeks Delivery Format The Latest Updated PDF and Excel Data file

Published:May-2025

Disposable Medical Needle Market Analysis and Outlook Report: Industry Size, Share, Growth Trends, and Forecast (2025-2034)

The Disposable Medical Needle Market plays a vital role in global healthcare infrastructure, providing safe and hygienic solutions for various medical procedures, including drug delivery, blood collection, vaccination, and intravenous therapy. As healthcare providers continue to emphasize infection control and patient safety, the demand for single-use needles has surged. These needles are designed for one-time use to prevent cross-contamination and the transmission of infectious diseases. The market encompasses a wide array of needle types such as hypodermic needles, blood collection needles, and suture needles, among others. A growing number of surgeries, immunization programs, and chronic disease cases are fueling consistent demand, making disposable needles an indispensable element in hospitals, clinics, diagnostic centers, and home healthcare settings. In recent years, the Disposable Medical Needle Market has experienced a technological shift with increasing incorporation of safety-engineered needles that feature retractable designs and needle shielding mechanisms to reduce needlestick injuries. Regulatory policies in developed countries have further encouraged the adoption of such devices, pushing manufacturers to innovate. Emerging economies are also witnessing a rising uptake due to expanding public health initiatives and improving healthcare infrastructure. Furthermore, the rise in point-of-care diagnostics and home-based treatments is broadening the market’s consumer base. The market’s competitive landscape is defined by strategic collaborations, geographic expansions, and the development of cost-effective, eco-conscious solutions tailored to meet local and global medical standards. Key Takeaways Increasing prevalence of chronic diseases such as diabetes and cancer is driving sustained demand for disposable medical needles for ongoing treatments and diagnostics. Government immunization programs, especially in developing regions, are significantly boosting the consumption of single-use needles in mass vaccination campaigns. Stringent health and safety regulations in North America and Europe are promoting the use of safety-engineered disposable needles to reduce occupational hazards. Technological advancements are enabling the production of ultra-thin, pain-minimizing needles that enhance patient comfort during routine and specialty procedures. Asia-Pacific is emerging as the fastest-growing regional market due to healthcare infrastructure development, medical tourism, and favorable regulatory reforms. Rising awareness among healthcare workers about the dangers of needlestick injuries is fostering adoption of auto-disable and retractable needle types. Single-use needle demand is gaining traction in home-based care settings, especially for insulin administration and self-injectable medications. Supply chain disruptions have led to an increase in regional production capabilities and strategic sourcing to ensure uninterrupted needle supply. Eco-friendly initiatives are encouraging the development of biodegradable or recyclable disposable needles to minimize medical waste. Public-private partnerships are expanding healthcare access and creating demand for low-cost disposable medical supplies in underserved areas. Online distribution and e-commerce platforms are enabling smaller clinics and consumers to access a variety of disposable medical needle products more conveniently. Leading companies are pursuing acquisitions and R&D investments to develop patent-protected needle designs and expand their safety product portfolios. Hospital consolidations and group purchasing organizations (GPOs) are influencing pricing strategies and supplier competitiveness within the market. Localized manufacturing is helping companies reduce costs and comply with domestic regulatory standards, boosting market penetration in low- and middle-income countries. Ongoing innovation in needle coatings and materials is aimed at reducing patient discomfort, improving durability, and enhancing sterility assurance. Parameter Detail Base Year 2024 Estimated Year 2025 Forecast Period 2026-2032 Market Size-Units USD billion Market Splits Covered By Product Type, By Application, By End User, By Technology, By Distribution Channel Countries Covered North America (USA, Canada, Mexico) Europe (Germany, UK, France, Spain, Italy, Rest of Europe) Asia-Pacific (China, India, Japan, Australia, Rest of APAC) The Middle East and Africa (Middle East, Africa) South and Central America (Brazil, Argentina, Rest of SCA) Analysis Covered Latest Trends, Driving Factors, Challenges, Trade Analysis, Price Analysis, Supply-Chain Analysis, Competitive Landscape, Company Strategies Customization 10% free customization (up to 10 analyst hours) to modify segments, geographies, and companies analyzed Post-Sale Support 4 analyst hours, available up to 4 weeks Delivery Format The Latest Updated PDF and Excel Datafile

Published:May-2025